In renal and cervical cancer, high expression of ZDHHC8 is significantly correlated with shorter survival times, whereas in lung and pancreatic cancers high expression significantly correlates with longer survival rates (S1A Fig). Here, ZDHHC8 is linked to cervical carcinoma.